[The perception gap on migraine: a survey study of the migraine patients, family members, and physicians].

migraine patient-centered care patient-family relations physician-patient relations self report

Journal

Rinsho shinkeigaku = Clinical neurology
ISSN: 1882-0654
Titre abrégé: Rinsho Shinkeigaku
Pays: Japan
ID NLM: 0417466

Informations de publication

Date de publication:
22 Jun 2024
Historique:
medline: 24 6 2024
pubmed: 24 6 2024
entrez: 23 6 2024
Statut: aheadofprint

Résumé

Migraine is a disease that is difficult to be recognized by those around the patients, even though it causes significant hindrances. In this study, we conducted an exploratory comparison of the perceptions on migraine among patients, family members living with them, and physicians treating migraine patients. Patients and family members shared a common understanding on the pain of migraine, and hoped to spend more/better time together as a family. However, although family members felt compassion for the patients, lack of understanding by and patients' concern for the surroundings led to feelings of resignation and endurance on the side of patients. Regarding physicians' medical care, our results suggested the importance to understand the wishes and obstacles of each patient and to propose treatment accordingly. In order to reduce the burden of migraine, it is necessary to create an environment and raise awareness that allows people around the patients to understand and support the pain and hopes that each patient feels.

Identifiants

pubmed: 38910117
doi: 10.5692/clinicalneurol.cn-001950
doi:

Types de publication

English Abstract Journal Article

Langues

jpn

Sous-ensembles de citation

IM

Auteurs

Shiho Suzuki (S)

Department of Neurology, Dokkyo Medical University.

Mamoru Shibata (M)

Department of Neurology, Ichikawa General Hospital, Tokyo Dental College.

Daisuke Danno (D)

Department of Neurology, Tominaga Hospital.

Yoshinori Tanizawa (Y)

Japan Drug Development and Medical Affairs, Eli Lilly Japan K.K.

Satoshi Osaga (S)

Japan Drug Development and Medical Affairs, Eli Lilly Japan K.K.

Masayuki Hamakawa (M)

Social Survey Research Information Co., Ltd.

Mika Komori (M)

Japan Drug Development and Medical Affairs, Eli Lilly Japan K.K.

Classifications MeSH